U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
101069101069Endoscopic Retrograde Cholangiopancreatography (ERCP) With Cholangiopancreatoscopy Using a Thin ScopeWithdrawnNo Results AvailableDisorders of the Pancreatobiliary SystemProcedure: Endoscopic Retrograde Cholangiopancreatography (ERCP)with Cholangiopancreatoscopy using the thin scopehttps://ClinicalTrials.gov/show/NCT01242995
101070101070Subcapital and Shaft Fractures of the 5. MetacarpalTerminatedNo Results AvailableFractureProcedure: Closed reduction and fixation with 2 pins|Procedure: Reduction and Plaster of Parishttps://ClinicalTrials.gov/show/NCT01242982
101041101041Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid MalignanciesCompletedNo Results AvailableClear Cell Renal Cell Carcinoma|Recurrent Renal Cell Cancer|Stage I Renal Cell Cancer|Stage II Renal Cell Cancer|Stage III Renal Cell Cancer|Stage IV Renal Cell Cancer|Unspecified Adult Solid Tumor, Protocol SpecificDrug: sunitinib malate|Biological: bevacizumab|Other: pharmacological study|Other: laboratory biomarker analysis|Other: fluorine F 18 fluorothymidine|Procedure: positron emission tomography|Procedure: computed tomographyhttps://ClinicalTrials.gov/show/NCT01243359
101042101042Phase II Study of Crenolanib (CP-868,596), for the Treatment of Patients With Advanced Gastrointestinal Stromal Tumors With the D842-related Mutations and Deletions in the PDGFRA GeneCompletedNo Results AvailableD842-related Mutant GISTDrug: Crenolanib besylate (CP-868,596-26), Dose: 140mg BIDhttps://ClinicalTrials.gov/show/NCT01243346
101043101043Multi-Tracer PET in Early Phase TrialsRecruitingNo Results AvailableCancerRadiation: Multi-tracer PET examshttps://ClinicalTrials.gov/show/NCT01243333
101044101044In Vivo Assessment of Silver Biomaterial Nano-ToxicityCompletedHas ResultsHealthyDrug: 10ppm Oral Silver Particle|Drug: 32ppm Oral Silver Particlehttps://ClinicalTrials.gov/show/NCT01243320
101045101045A Study to Investigate the Pharmacodynamic Effects of CT327 on Intra-dermal Nerve Growth Factor (NGF) and Evoked Pain Responses, in Healthy Male VolunteersCompletedNo Results AvailableNeuropathic PainDrug: CT327 (or placebo) followed by placebo (or CT327)https://ClinicalTrials.gov/show/NCT01243307
101046101046Study Evaluating a New Ostomy Appliance With Regard to Leakage, Handling and ComfortCompletedHas ResultsColostomyDevice: SS|Device: SenSurahttps://ClinicalTrials.gov/show/NCT01243294
101047101047Pegylated Interferon Alpha-2b Monotherapy Versus Combination With Entecavir in HBeAg-negative Chronic Hepatitis BRecruitingNo Results AvailableChronic Hepatitis BDrug: PEG-IFN and entecavirhttps://ClinicalTrials.gov/show/NCT01243281
101048101048A Regulatory Requirement Post-Marketing Surveillance Study to Monitor the Safety and Efficacy of Twynsta (Telmisartan + Amlodipine SPC, q.d.) in Korean Hypertensive Patients Requiring Combination TherapyRecruitingNo Results AvailableHypertensionDrug: Twynsta tablethttps://ClinicalTrials.gov/show/NCT01243268
101049101049Polish Survey on the Efficacy of the Hypercholesterolemia TreatmentCompletedNo Results AvailableHypercholesterolemiahttps://ClinicalTrials.gov/show/NCT01243255
101050101050Clinical Efficacy & Safety, of Metadoxine (MG01CI) Extended Release in Attention-Deficit Hyperactivity Disorder (ADHD)CompletedHas ResultsADHDDrug: Metadoxine (MG01CI)https://ClinicalTrials.gov/show/NCT01243242
101051101051Genetic Analysis of Congenital Diaphragmatic DisordersRecruitingNo Results AvailableCongenital Diaphragmatic Hernia|Congenital Diaphragmatic Eventration|Congenital Hiatal Hernia|Congenital Diaphragmatic Disordershttps://ClinicalTrials.gov/show/NCT01243229
101052101052Does Ultrasound of the Spine Improve Labor Epidurals/Spinal Anesthesia in Obstetric Patients?RecruitingNo Results AvailablePregnancy|Labor Pain|Cesarean DeliveryDevice: Ultrasoundhttps://ClinicalTrials.gov/show/NCT01243216
101053101053Smoking Cessation Program in the Preadmission Clinic: The Use of a Teachable MomentCompletedNo Results AvailableSmokingDrug: Champixhttps://ClinicalTrials.gov/show/NCT01243203
101054101054Ofatumumab for High-Risk Chronic Lymphocytic Leukemia (CLL)Active, not recruitingNo Results AvailableChronic Lymphocytic LeukemiaDrug: Ofatumumabhttps://ClinicalTrials.gov/show/NCT01243190
101055101055Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and OlderCompletedNo Results AvailableEpilepsy|MonotherapyDrug: Lacosamide|Drug: Carbamazepine-Controlled Releasehttps://ClinicalTrials.gov/show/NCT01243177
101056101056Efficacy of Wheelchair Skills Training on Confidence Using a Manual WheelchairCompletedNo Results AvailableConfidence Using a WheelchairOther: Wheelchair Skills Training Programhttps://ClinicalTrials.gov/show/NCT01243164
101057101057Safety And Tolerability Of Multiple Doses Of PF-04950615 (RN316) In Subjects With HypercholesterolemiaCompletedNo Results AvailableHypercholesterolemia|DyslipidemiaBiological: PF-04950615 (RN316)|Biological: PF-04950615 (RN316)|Biological: PF-04950615 (RN316)|Biological: PF-04950615 (RN316)|Biological: PF-04950615 (RN316)https://ClinicalTrials.gov/show/NCT01243151
101058101058Africa and Middle East Cardiovascular Epidemiological StudyCompletedNo Results AvailableObesity|Smoking|Dyslipidemia|Diabetes Mellitus|Hypertensionhttps://ClinicalTrials.gov/show/NCT01243138
101059101059Study to Evaluate NVC-422 for Urinary Catheter Blockage and EncrustationCompletedNo Results AvailableUrinary Catheter Blockage and EncrustationDrug: NVC-422, 0.2%|Drug: Sterile normal saline, 0.9%https://ClinicalTrials.gov/show/NCT01243125
101060101060Effectiveness Study of Different Local Anesthetic MixturesCompletedHas ResultsPainDrug: 1% Lidocaine with Epinephrine (1:100,000)|Drug: 0.25% Bupivacaine with Epinephrine (1:200,000)|Drug: 0.5% Lidocaine, 0.125 Bupivacaine, and epi (1:150,000)|Drug: 1% Lidocaine, 0.5% Bupivacaine, and epinephrine (1:150,000)https://ClinicalTrials.gov/show/NCT01243112
101061101061Prospective Study to Assess DES Re-endothelization in BMS Restenosis and De-novo LesionsCompletedNo Results AvailableStable Coronary Artery Disease|Silent Myocardial Ischemia|In-stent(BMS)Restenosis|De-novo, Atherosclerotic, Coronary Lesionshttps://ClinicalTrials.gov/show/NCT01243099
101062101062OZURDEX in Age Related Macular Degeneration as Adjunct to RanibizumabRecruitingNo Results AvailableWet Macular DegenerationDrug: Ranibizumab|Drug: OZURDEXhttps://ClinicalTrials.gov/show/NCT01243086
101063101063Open Label Study to Evaluate the Activity of Imetelstat in Patients With Essential Thrombocythemia or Polycythemia VeraCompletedNo Results AvailableEssential Thrombocythemia|Polycythemia VeraDrug: Imetelstathttps://ClinicalTrials.gov/show/NCT01243073
101064101064Effect of a Hypocretin/Orexin Antagonist on Neurocognitive PerformanceCompletedNo Results AvailableHealthy VolunteersDrug: Almorexant|Drug: Almorexant|Drug: Zolpidem 10mg|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01243060
101065101065Intermittent Versus Continuous Tarceva StudyCompletedNo Results AvailableMetastatic Colorectal CancerDrug: Chemotherapyhttps://ClinicalTrials.gov/show/NCT01243047
101066101066Waist Circumference Measurements in Schizophrenic PatientsNot yet recruitingNo Results AvailableWaist Circumference Measurements|Schizophrenia|Cardiovascular Risk Factorhttps://ClinicalTrials.gov/show/NCT01243034
101067101067Validation of an Early Warning Score Based Triage System in the Emergency DepartmentCompletedNo Results AvailableCritical Illnesshttps://ClinicalTrials.gov/show/NCT01243021
101068101068Safety, Skin and Plasma Concentration of Azithromycin Dermal FormulationCompletedNo Results AvailableLyme DiseaseDrug: Application of SHB001https://ClinicalTrials.gov/show/NCT01243008

* Görseller ve İçerik tekif hakkına sahip olabilir